Endo To Submit Response To FDA On Lidoderm Bioequivalence Recommendation
This article was originally published in The Pink Sheet Daily
Executive Summary
Endo argues bioequivalence of the lidocaine patch should be demonstrated through clinical efficacy study, not pharmacokinetic data.